» Articles » PMID: 33192995

Thyroid Diseases Are an Underestimated Risk Factor for Cerebral Venous Sinus Thrombosis

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Nov 16
PMID 33192995
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral venous sinus thrombosis (CVST) is a rare disease that generally accounts for just 1% of all strokes. Of the multiple risk factors that have been identified, the most common are genetic or acquired thrombophilia and the use of oral contraceptives, while the less common include local infections and mechanical causes. Thyroid diseases have been described as rare risk factors for CVST (<2% of all cases), without exact knowledge of the underlying pathophysiology. This retrospective study aimed to re-evaluate the relevance of thyroid disease as risk factor for CVST, with particular emphasis on hyperthyroidism. Confirmed cases of CVST were (re-)evaluated in terms of risk factors including thyroid parameters. Results were compared to previous data from the International Study on CVST. Between 1996 and 2016, 182 patients with confirmed CVST were treated in our hospital with a median age of 44 years and a female proportion of 74.7%. Genetic or acquired thrombophilia along with the use of oral contraceptives were found to be the most common risk factors. Thyroid diseases were present in 20.9% of CVST patients; this included patients with previous (9.9%) and current thyroid dysfunction (11%). Thyroid diseases may represent a more common risk factor for CVST than previously described. This holds true even if patients with current thyroid dysfunction are purely taken into account. However, 58% of patients had more than one additional risk factor, suggesting a multifactorial hypercoagulability. : Registered at the German Clinical Trials Register: http://www.drks.de, DRKS00017044.

Citing Articles

Association Between Thyrotoxicosis and Cerebral Venous Thrombosis.

Paccagnella M, Pizzo A, Calabro V, Velardi V, Fabris B, Bernardi S J Clin Med. 2024; 13(21).

PMID: 39518686 PMC: 11546735. DOI: 10.3390/jcm13216547.


Associations between deep venous thrombosis and thyroid diseases: a two-sample bidirectional Mendelian randomization study.

Zhang L, Li K, Yang Q, Lin Y, Geng C, Huang W Eur J Med Res. 2024; 29(1):327.

PMID: 38877527 PMC: 11177513. DOI: 10.1186/s40001-024-01933-1.


Cerebral Venous Thrombosis during Thyrotoxicosis: Case Report and Literature Update.

Raho E, Antonioni A, Cotta Ramusino N, Jubea D, Gragnaniello D, Franceschetti P J Pers Med. 2023; 13(11).

PMID: 38003871 PMC: 10672691. DOI: 10.3390/jpm13111557.


Thyroid Dysfunction in Patients with and Without Venous Thromboembolism: a Case Control Study.

Naushad R, Selvaraj J, Sahoo J, Viswanathan S, Murugesan R Indian J Hematol Blood Transfus. 2023; 39(4):649-654.

PMID: 37786825 PMC: 10542045. DOI: 10.1007/s12288-023-01643-4.


Cerebral Sinus Vein Thrombosis and Gender: A Not Entirely Casual Relationship.

Ciarambino T, Crispino P, Minervini G, Giordano M Biomedicines. 2023; 11(5).

PMID: 37238951 PMC: 10216036. DOI: 10.3390/biomedicines11051280.


References
1.
Franchini M . Hemostasis and thyroid diseases revisited. J Endocrinol Invest. 2005; 27(9):886-92. DOI: 10.1007/BF03346287. View

2.
Pekdemir M, Yilmaz S, Ersel M, Sarisoy H . A rare cause of headache: cerebral venous sinus thrombosis due to hyperthyroidism. Am J Emerg Med. 2008; 26(3):383.e1-2. DOI: 10.1016/j.ajem.2007.05.029. View

3.
Geisbusch C, Lichy C, Richter D, Herweh C, Hacke W, Nagel S . [Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years]. Nervenarzt. 2014; 85(2):211-20. DOI: 10.1007/s00115-013-4000-8. View

4.
Franchini M . Hemostatic changes in thyroid diseases: haemostasis and thrombosis. Hematology. 2007; 11(3):203-8. DOI: 10.1080/10245330600667591. View

5.
Hampel R, Kuhlberg T, Zollner H, Klinke D, Klein K, Pichmann E . [Current state of alimentary iodine deficiency in Germany]. Z Ernahrungswiss. 1996; 35(1):2-5. DOI: 10.1007/BF01612021. View